CAL
WST icon

Capital Analysts LLC’s West Pharmaceutical WST Stock Holding History

Capital Analysts LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,960
Closed -$642K – 1432
2024
Q4 		$642K Hold
1,960
– – 0.03% 303
2024
Q3 		$588K Buy
1,960
+235
+14% +$72K 0.02% 300
2024
Q2 		$568K Hold
1,725
– – 0.03% 311
2024
Q1 		$683K Hold
1,725
– – 0.03% 286
2023
Q4 		$607K Sell
1,725
-50
-3% -$17.7K 0.03% 293
2023
Q3 		$666K Sell
1,775
-170
-9% -$65.7K 0.04% 261
2023
Q2 		$744K Hold
1,945
– – 0.04% 251
2023
Q1 		$674K Buy
1,945
+5
+0.3% +$1.46K 0.04% 264
2022
Q4 		$457K Sell
1,940
-45
-2% -$10.7K 0.03% 309
2022
Q3 		$488K Sell
1,985
-601
-23% -$183K 0.03% 271
2022
Q2 		$782K Buy
2,586
+25
+1% +$8.13K 0.05% 231
2022
Q1 		$1.05M Hold
2,561
– – 0.07% 213
2021
Q4 		$1.2M Sell
2,561
-29
-1% -$12.5K 0.07% 202
2021
Q3 		$1.1M Hold
2,590
– – 0.07% 203
2021
Q2 		$929K Buy
2,590
+35
+1% +$11.6K 0.06% 211
2021
Q1 		$720K Buy
2,555
+635
+33% +$182K 0.05% 226
2020
Q4 		$544K Buy
1,920
+340
+22% +$95.4K 0.05% 186
2020
Q3 		$434K Buy
1,580
+165
+12% +$43.7K 0.04% 203
2020
Q2 		$321K Sell
1,415
-80
-5% -$15.7K 0.03% 202
2020
Q1 		$228K Buy
+1,495
New +$230K 0.03% 199

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Capital Analysts LLC's WST Position: Q1 2025 in Review

Capital Analysts LLC sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 1,960 shares — an estimated $642K sold.

Capital Analysts LLC first reported a position in WST in Q1 2020 and held it in 20 quarters. The position peaked at $1.2M in Q4 2021. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Capital Analysts LLC reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Capital Analysts LLC sold 1,960 West Pharmaceutical shares in Q1 2025, an estimated $642K.
  • Capital Analysts LLC first reported a position in West Pharmaceutical in Q1 2020 and held it in 20 quarters.
  • Capital Analysts LLC's West Pharmaceutical position peaked at $1.2M in Q4 2021.
  • 715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Capital Analysts LLC's 13F filing for Q1 2025, filed 14 May 2025.